Pierre Croisille Selected Research

Dipyridamole (Persantine)

10/2003	Myocardial perfusion and glucose uptake coupling in CAD patients.
1/2002	Factor analysis of medical image sequences improves evaluation of first-pass MR imaging acquisitions for myocardial perfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre Croisille Research Topics

Disease

14	Myocardial Infarction 01/2021 - 01/2002
13	Infarction (Infarctions) 01/2021 - 09/2006
10	ST Elevation Myocardial Infarction 01/2021 - 07/2008
5	Coronary Artery Disease (Coronary Atherosclerosis) 12/2011 - 01/2002
4	Ischemia 01/2023 - 07/2008
4	Reperfusion Injury 01/2023 - 07/2008
3	Fibrosis (Cirrhosis) 01/2023 - 11/2014
3	Thoracic Aortic Aneurysm 01/2021 - 11/2018
2	Bicuspid Aortic Valve Disease 06/2021 - 11/2018
2	Heart Failure 11/2020 - 10/2012
2	Rupture 01/2020 - 12/2018
2	Body Weight (Weight, Body) 01/2019 - 07/2008
2	Heart Diseases (Heart Disease) 11/2016 - 07/2012
2	Coronary Occlusion 03/2016 - 09/2010
2	Edema (Dropsy) 10/2012 - 06/2012
1	Cardiac Arrhythmias (Arrythmia) 01/2023
1	Shock 01/2023
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Necrosis 01/2022
1	Cardiotoxicity 03/2021
1	Neoplasms (Cancer) 03/2021
1	Hemorrhage 01/2021
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 06/2019
1	Aortic Valve Stenosis (Aortic Stenosis) 06/2019
1	Hypertension (High Blood Pressure) 12/2018
1	Inflammation (Inflammations) 10/2015
1	Myocarditis (Carditis) 10/2015
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2014
1	Ventricular Fibrillation 10/2012
1	Ventricular Remodeling 03/2010
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2006
1	Left Ventricular Dysfunction 10/2003
1	Myocardial Stunning (Stunned Myocardium) 10/2003

Drug/Important Bio-Agent (IBA)

9	GadoliniumIBA 01/2023 - 01/2002
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2015
5	N-acetylVal-Nle(7,8)- allatotropin (5-13) (ATAA)IBA 06/2021 - 11/2018
3	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021 - 07/2008
3	Contrast MediaIBA 11/2014 - 09/2006
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2010 - 07/2008
2	omega-Chloroacetophenone (Mace)IBA 01/2023 - 11/2020
2	Colchicine FDA LinkGeneric 01/2021 - 01/2021
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 10/2012 - 09/2009
2	Glucose (Dextrose)FDA LinkGeneric 11/2004 - 10/2003
2	Dipyridamole (Persantine)FDA LinkGeneric 10/2003 - 01/2002
1	Galectin 3 (LGALS3)IBA 01/2022
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2019
1	antineoplaston A10 (A 10)IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2017
1	EnzymesIBA 04/2011
1	Mitochondrial Permeability Transition PoreIBA 06/2010
1	Saline SolutionIBA 07/2008
1	Troponin IIBA 07/2008
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2003

Therapy/Procedure

10	Percutaneous Coronary Intervention 01/2021 - 07/2008
7	Therapeutics 01/2023 - 11/2008
2	Ischemic Postconditioning 11/2013 - 06/2010
2	Cardiac Resynchronization Therapy 10/2012 - 07/2012
1	Extracorporeal Shockwave Therapy 01/2023
1	Drug Therapy (Chemotherapy) 01/2023
1	Radiotherapy 03/2021
1	Radiofrequency Ablation 07/2012
1	Microspheres (Microsphere) 09/2010